Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Levobetaxolol Hcl
2. 116209-55-3
3. Betaxon
4. Levobetaxolol Hydrochloride [usan]
5. Levobetaxolol (hydrochloride)
6. Al1577a
7. Al-1577a
8. (s)-betaxolol Hydrochloride
9. 8mr4w4o06j
10. (-)-(s)-1-(p-(2-(cyclopropylmethoxy)ethyl)phenoxy)-3-(isopropylamino)-2-propanol Hydrochloride
11. (s)-1-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)-3-(isopropylamino)propan-2-ol Hydrochloride
12. 2-propanol, 1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-[(1-methylethyl)amino]-, Hydrochloride (1:1), (2s)-
13. 116209-55-3 (hcl); 93221-48-8 (free Base)
14. Levobetaxolol Hydrochloride (usan)
15. Chebi:59256
16. (s)-betataxolol Hydrochloride
17. Al 1577a
18. (s)-betaxolol Hydrochloride;al-1577a
19. Unii-8mr4w4o06j
20. Betaxon (tn)
21. Schembl42795
22. Chembl1200837
23. Hy-b0381b
24. Dtxsid20151321
25. (2s)-1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan-2-ylamino)propan-2-ol;hydrochloride
26. Bcp12964
27. S4085
28. Akos030485957
29. Ccg-267959
30. Cs-5154
31. 2-propanol, 1-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)-3-((1-methylethyl)amino)-, Hydrochloride, (2s)-
32. 2-propanol, 1-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)-3-((1-methylethyl)amino)-, Hydrochloride, (s)-
33. As-74909
34. Levobetaxolol Hydrochloride [mart.]
35. Levobetaxolol Hydrochloride [who-dd]
36. Sw219529-1
37. C71529
38. D04710
39. Levobetaxolol Hydrochloride [orange Book]
40. 116209-55-3, 93221-48-8(free Base)
41. Q27126573
42. (2s)-1-{4-[2-(cyclopropylmethoxy)ethyl]phenoxy}-3-[(propan-2-yl)amino]propan-2-ol Hydrochloride
43. 2-propanol, 1-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)-3-((1-methylethyl)amino)-, (2s)-, Hydrochloride
| Molecular Weight | 343.9 g/mol |
|---|---|
| Molecular Formula | C18H30ClNO3 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 11 |
| Exact Mass | 343.1914215 g/mol |
| Monoisotopic Mass | 343.1914215 g/mol |
| Topological Polar Surface Area | 50.7 Ų |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 286 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
A Levobetaxolol HCl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Levobetaxolol HCl, including repackagers and relabelers. The FDA regulates Levobetaxolol HCl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Levobetaxolol HCl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Levobetaxolol HCl supplier is an individual or a company that provides Levobetaxolol HCl active pharmaceutical ingredient (API) or Levobetaxolol HCl finished formulations upon request. The Levobetaxolol HCl suppliers may include Levobetaxolol HCl API manufacturers, exporters, distributors and traders.
Levobetaxolol HCl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Levobetaxolol HCl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Levobetaxolol HCl GMP manufacturer or Levobetaxolol HCl GMP API supplier for your needs.
A Levobetaxolol HCl CoA (Certificate of Analysis) is a formal document that attests to Levobetaxolol HCl's compliance with Levobetaxolol HCl specifications and serves as a tool for batch-level quality control.
Levobetaxolol HCl CoA mostly includes findings from lab analyses of a specific batch. For each Levobetaxolol HCl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Levobetaxolol HCl may be tested according to a variety of international standards, such as European Pharmacopoeia (Levobetaxolol HCl EP), Levobetaxolol HCl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Levobetaxolol HCl USP).
LOOKING FOR A SUPPLIER?
